Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curea vs Juvederm for Nasolabial Folds
NCT06574750Completed
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Oct 2021
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of hydroxyurea in nasolabial folds (2 arms), sponsored by Seoul National University Bundang Hospital. Primary endpoint: Wrinkle Severity Rating Scale at 24 weeks. Started Oct 2021; status: completed.
02
Drugs
hydroxyurea
03
Conditions
nasolabial folds
Beyond the preview
Go deeper on NCT06574750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06574750.